Authors:
Forissier, JF
Vernochet, P
Bertrand, P
Charbonnier, B
Monpere, C
Citation: Jf. Forissier et al., Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure, EUR J HE FA, 3(3), 2001, pp. 335-342
Authors:
Hamel, E
Pacouret, G
Vincentelli, D
Forissier, JF
Peycher, P
Pottier, JM
Charbonnier, B
Citation: E. Hamel et al., Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation - Results from a 128-patient monocenter registry, CHEST, 120(1), 2001, pp. 120-125
Authors:
Torbicki, A
van Beek, EJR
Charbonnier, B
Meyer, G
Morpurgo, M
Palla, A
Perrier, A
Galie, N
Gorge, G
Herold, C
Husted, S
Jezek, V
Kasper, W
Kneussl, M
Morice, AH
Musset, D
Samama, MM
Simonneau, G
Sors, H
de Swiet, M
Turina, M
Kronik, G
Widimsky, J
Citation: A. Torbicki et al., Guidelines on diagnosis and management of acute pulmonary embolism, EUR HEART J, 21(16), 2000, pp. 1301-1336
Authors:
Meignan, M
Rosso, J
Gauthier, H
Brunengo, F
Claudel, S
Sagnard, L
d'Azemar, P
Simonneau, G
Charbonnier, B
Citation: M. Meignan et al., Systematic lung scans reveal a high frequency of silent pulmonary embolismin patients with proximal deep venous thrombosis, ARCH IN MED, 160(2), 2000, pp. 159-164
Authors:
Forissier, JF
Maillard, L
Toban, P
Sirinelli, A
Casset-Senon, D
Eder, V
Bertrand, P
Pacouret, G
Raynaud, P
Charbonnier, B
Citation: Jf. Forissier et al., Diagnostic value of dobutamine stress echocardiography and exercise myocardial scintigraphy for restenosis at 6 months after angioplasty of the left anterior descending artery., ARCH MAL C, 93(6), 2000, pp. 711-717
Authors:
Maillard, L
Loose, C
Desveaux, B
Quilliet, L
Delplace, C
Fichaux, O
Arwidson, P
Pacouret, G
Charbonnier, B
Raynaud, P
Citation: L. Maillard et al., Hospital results of salvage angioplasty with coronary stenting after failure of thrombolysis in the acute phase of myocardial infarction., ARCH MAL C, 93(4), 2000, pp. 347-353
Authors:
Vermeer, F
Bosl, I
Meyer, J
Bar, F
Charbonnier, B
Windeler, J
Barth, H
Citation: F. Vermeer et al., Saruplase is a safe and effective thrombolytic agent; Observations in 1698patients: Results of the PASS study, J THROMB TH, 8(2), 1999, pp. 143-150
Authors:
Guerrero, RAA
Amuchastegui, M
Badaracco, J
Elizari, M
Martellotto, R
De la Hoz, RP
Ramos, JL
Salvati, AM
Sinisi, A
Torre, H
Aroney, G
Campbell, T
Garrahy, P",Lalman,"Liebens, I
Renard, M
Bastecky, J
Bocek, P
Cepelak, V
Dvorak, K
Gregor, J
Janousek, S
Jansky, P
Jirmar, R
Kamenik, L
Rybka, J
Spacek, R
Spinar, J
Svitil, P
Zeman, K
Alagha, Z
Allam, S
Barnay, C
Baudouy, M
Beltran, J
Berland, J
Berthou, JD
Bery, E
Bessede, G
Beygui, F
Bickert, P
Boshat, J
Boulenc, JM
Bourlard, P
Bouthillier, D
Brandt, C
Cattan, S
Charbonnier, B
Citron, B
Coisne, D
Coupillaud, J
Da Costa, A
Dambrine, P
Danchin, N
Delarche, N
Dequeker, JL
Desjouaux, E
Dievart, F
Dujardin, JJ
Durand, P
Fadel, N
Fichter, P
Galinier, M
Gryman, R
Gauthier, J
Geslin, P
Godard, S
Grollier, G
Guerot, C
Gully, C
Janin-Manificat, L
Joly, P
Joseph, T
Juillard, A
Ketelers, JY
Lagorce, P
Laine, E
Lang, M
Lanney-Courten, JE
Le Helloco, A
Ledru, F
Levy, S
Litvine-Itaya, L
Lopez, M
Mansour, M
Mathurin, C
Meyer, G
Mossaz, R
Nedelec, G
Ollitrault, J
Pacouret, G
Perchet, H
Poitrineau, O
Richard, M
Rocher, R
Rougier, L
Sagnol, P
Tardieu, A
Thery, C
Thieuleux, F
Touboul, P
Tran-Tanh, X
Veyrat, A
Villarem, D
Werquin, S
Skoufas, P
Fotiadis, I
Xenodochidis, C
Karidis, K
Limberi, S
Papasteriadis, E
Giokas, K
Kremastinos, D
Polichronaki, E
Moshos, N
Daskalakis, I
Janecsko, M
Janosi, A
Kalo, E
Karpati, P
Mezofi, M
Nyaradi, A
Ofner, P
Oze, B
Poor, F
Preda, I
Ronaszeki, A
Valyi, P
Zamolyi, K
Davini, P
Martines, C
Melandri, F
Pasotti, C
Pettinati, G
Veze, I
Kochkarev, F
Erpelding, J
Halaczkiewicz, H
Ilmuzynska, K
Kurowski, M
Lasota-Czopnik, A
Markiewicz, M
Musial, W
Nartowicz, E
Pasyk, S
Prastowski, W
Ruszkowski, J
Sadowski, Z
Sas, M
Stopinski, M
Ujda, M
Wojciechowski, D
Diniz, M
Drumond, A
Rodrigues, P
Pereira, MA
Correia, A
Scherbak, A
Irklienko, K
Dudko, L
Goloschekin, B
Maximova, G
Sorokin, L
Inyushin, A
Bzhelianskaia, V
Kostenko, V
Stefanenko, M
Bilich, A
Froufe, G
Masip, J
Pajaron, A
Roura, J
Sanz, G
Valle, V
Caduff, B
Moccetti, T
Noseda, G
Simonin, C
Baars, HF
Bernink, PJLM
Daniels, MCG
Gobel, E
Nagelsmit, MJ
Ramdat, AR
Senden, PJ
van Rossum, P
van Wijk, LM
Withagen, AJAM
Crowe, PF
Davidson, C
Handler, CE",McNeil,"Molajo, AO
Citation: Raa. Guerrero et al., Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS (FRAxiparine in Ischaemic Syndrome), EUR HEART J, 20(21), 1999, pp. 1553-1562